Pfizer plans to charge $110 to $130 for its Covid-19 vaccine dose, almost quadrupling the current price, once the federal government relinquishes its role as dominant purchaser. Evidently, part of this transition consists of raising prices to further boost revenues and profits of vaccine makers.